Community College Funding Shrinks, For-Profit Enrollment Grows: Treasury Report

A report released this month by the U.S. Treasury Department shows a correlation between state budget cuts to community colleges over the past decade and a growth in enrollment at for-profit colleges.

The report, titled "The Economics of Higher Education," examined both employment and income characteristics of Americans who attain some form of a post-secondary education alongside funding and tuition costs at public and private colleges.

The report notes that more high school students are graduating and going on to colleges and universities. Most attend public schools, many with shrinking state funding, which puts added pressure on community colleges:

Community colleges are highly dependent on state funding since, unlike four-year, public schools, they do not have diversified revenue sources such as hospitals, endowments, or research grants. While enrollments have been increasing, state support per student has remained relatively flat. In 2009, community colleges received approximately $6,450 per FTE (full-time equivalent) student, only slightly higher than the $6,210 in 1999,

According to the report, the funding decline for public colleges and universities bottomed out in 2005, then slightly increased before dropping again in 2008.

Because of the budget squeeze, community colleges are pushed to either raise tuition or or to limit class size, and often choose the latter, leading to a correlating spike in for-profit college enrollment. According to the report, community colleges are "more likely to serve low-income and first-generation student populations than four-year schools, and these students now constitute the bulk of the student population at for-profit schools."

For their part, for-profit colleges are targeting these low-income students in their marketing and recruitment efforts, court documents revealed earlier this year.

At the for-profits, students are more likely to default on their student loans and struggle to find work, compared to their counterparts at public colleges. The average graduation rate at for-profit colleges is unimpressive, often falling below 30 percent, compared to public and private non-profits with graduation rates above 65 percent.

Despite these dismal figures, the number of students attending for-profit colleges grew from 200,000 students in the late 1980s to nearly 2 million students today, representing 9 percent of all higher education enrollment, the report found.

The continued success of for-profits could be because the "college wage gap" is as wide as ever, since it was first estimated in 1915. The report notes college graduates in 2012 are statistically fully employed and make 64 percent more than those with just a high school diploma. Without a college degree, children born to families at the lowest income level have a 45 percent chance of remaining at that level, but they are more likely to earn more with a greater degree of education.

From the report:

Also on HuffPost:

"; var coords = [-5, -72]; // display fb-bubble FloatingPrompt.embed(this, html, undefined, 'top', {fp_intersects:1, timeout_remove:2000,ignore_arrow: true, width:236, add_xy:coords, class_name: 'clear-overlay'}); });

Source: http://www.huffingtonpost.com/2012/12/26/community-college-for-profit_n_2340958.html

andrew breitbart dead sheriff joe arpaio limbaugh aaron smith wilt chamberlain joe arpaio cat in the hat

Phil Gramm: The Multiple Distortions of Wind Subsidies (WSJ)

Share With Friends: | | Politics - Top Stories News, RSS Feeds and Widgets via Feedzilla.

Source: http://news.feedzilla.com/en_us/stories/politics/top-stories/273107283?client_source=feed&format=rss

mad hatter azerbaijan ryan howard ps i love you ray charles cheney heart transplant weather san diego

Daily Kos: The Five Biggest Regrets of the Dying

For those wondering; in the book, there was no mention of more sex or bungee jumps.

Instead, Ware, a nurse who specializes in palliative care has counselled the dying in their last days and in her book, revealed the most common regrets that we have at the end of our lives.

Interestingly for me, among the top from men in particular, is 'I wish I hadn't worked so hard'.

*Editor's Note - Most of the patients that she is recording are in the last 12 week of their lives and they are AWARE OF THIS.*

In her book, Ware writes of the phenomenal clarity of vision that people gain at the end of their lives, and how we might learn from their wisdom. "When questioned about any regrets they had or anything they would do differently," she says, "common themes surfaced again and again."

Here are the top five regrets of the dying, as witnessed by Ware in her book The Top Five Regrets of The Dying:

1. I wish I'd had the courage to live a life true to myself, not the life others expected of me.

"This was the most common regret of all. When people realize that their life is almost over and look back clearly on it, it is easy to see how many dreams have gone unfulfilled.

Most people had not honored even a half of their dreams and had to die knowing that it was due to choices they had made, or not made. Health brings a freedom very few realize ?until they no longer have it."

2. I wish I hadn't worked so hard.

"This came from every male patient that I nursed. They missed their children's youth and their partner's companionship. Women also spoke of this regret, but as most were from an older generation, many of the female patients had not been breadwinners.

All of the men that Bronnie nursed deeply regretted spending so much of their lives on the treadmill of a work existence."

3. I wish I'd had the courage to express my feelings.

"Many people suppressed their feelings in order to keep peace with others. As a result, they settled for a mediocre existence and never became who they were truly capable of becoming.

Many developed illnesses, relating to the bitterness and resentment they carried as a result."

4. I wish I had stayed in touch with my friends.

"Often they would not truly realize the full benefits of old friends until their dying weeks and it was not always possible to track them down. Many had become so caught up in their own lives that they had let golden friendships slip by over the years.

There were many deep regrets about not giving friendships the time and effort that they deserved. Everyone misses their friends when they are dying."

5. I wish that I had let myself be happier.

"This is a surprisingly common one. Many did not realize until the end that happiness is a choice. They had stayed stuck in old patterns and habits. The so-called 'comfort' of familiarity overflowed into their emotions, as well as their physical lives.

Fear of change had them pretending to others, and to their selves, that they were content, when deep within, they longed to laugh properly and have silliness in their life again."

With many of us living with regret; think about this deeply. ?What's your greatest regret so far, and what will you set out to achieve or change before you die?

For the original story : ?Caf? Con Leche

Source: http://www.dailykos.com/story/2012/12/26/1173973/-The-Five-Biggest-Regrets-of-the-Dying

judi dench bobby brown leaves funeral donnie mcclurkin whitney houston funeral live stream kevin costner whitney houston whitney houston funeral live pat buchanan

Mayo Clinic - Ability to Metabolize Tamoxifen Affects Breast Cancer ...

Wednesday, December 26, 2012

ROCHESTER, Minn. ? For nearly a decade, breast cancer researchers studying the hormone therapy tamoxifen have been divided as to whether genetic differences in a liver enzyme affect the drug's effectiveness and the likelihood breast cancer will recur. A new study by researchers from the Mayo Clinic Cancer Center and the Austrian Breast and Colorectal Cancer Study Group provides evidence that genetic differences in the enzyme CYP2D6 play a key role in how well tamoxifen works.

MULTIMEDIA ALERT:: Video of Dr. Goetz is available on the Mayo Clinic News Network.

"Our findings confirm that, in early breast cancer treated with tamoxifen, genetic alterations in CYP2D6 lead to a higher likelihood of recurrence and death," says Mayo Clinic oncologist Matthew Goetz, M.D., lead author of the study in the journal Clinical Cancer Research.

In the clinical trial, Dr. Goetz and his colleagues studied the rates of cancer recurrence and death in two groups: postmenopausal women with primary estrogen receptor-positive breast cancer who received tamoxifen for five years and those who received tamoxifen for two years followed by the aromatase inhibitor anastrozole for three years. Anastrozole is a breast cancer drug whose metabolism does not require the CYP2D6 enzyme.

The study showed that women who were born with genetic alterations of CYP2D6 that abolish the enzyme's critical metabolizing activity and who took tamoxifen for five years had recurrence of breast cancer, or died at a rate 2.5 times higher than women with normal CYP2D6 enzyme activity. Women with intermediate levels of the CYP2D6 enzyme had rates of recurrence or death 1.7 times higher than women with normal CYP2D6 activity. Importantly, Dr. Goetz notes, that genetic alterations in CYP2D6 did not affect the likelihood of recurrence or death in women who switched to anastrozole after two years of tamoxifen.

"Switching from tamoxifen to an aromatase inhibitor may be one reason for the discrepant studies surrounding CYP2D6 and tamoxifen ? as information about whether a patient took an aromatase inhibitor after tamoxifen was not available in most of the prior studies," says senior author James Ingle, M.D., of Mayo Clinic, an expert on hormone therapies for breast cancer.

A blood test can determine whether a woman has alterations in CYP2D6 and predict how efficiently her body will convert tamoxifen to endoxifen. Approximately 5 to 7 percent of European and North American populations are considered poor metabolizers of tamoxifen.

"The results of this successful high-level international research collaboration are an important step forward in our quest to individualize breast cancer treatment and provide tailored care to women with breast cancer," says Michael Gnant, M.D., professor of surgery at the Medical University of Vienna and president of the Austrian study group.

So what should a woman do if she is unable to effectively metabolize tamoxifen into its most active form? Dr. Goetz believes that the current recommendation of switching from tamoxifen to an aromatase inhibitor is likely to result in the greatest benefit in women with decreased CYP2D6 metabolism. For CYP2D6 poor metabolizers, avoiding tamoxifen altogether and starting out with an aromatase inhibitor may be the best approach, he says.

Dr. Goetz's group is working with the National Cancer Institute to develop endoxifen as an alternative to tamoxifen. If women can be given endoxifen, the active part of tamoxifen, it won't matter how tamoxifen gets metabolized, he says.

The study is partially funded by the National Institutes of Health, co-authors include Vera Suman, Ph.D.; Tanya Hoskin; Mary Kuffel; Stephanie Safgren; Carol Reynolds, M.D.; Matthew Ames, Ph.D.; and Richard Weinshilboum, M.D., all of Mayo Clinic; Martin Filipits, Ph.D.; Raimund Jakesz and Margaretha Rudas of the Medical University of Vienna; Richard Greil and Otto Dietze of Paracelsus Medical University, Salzburg, Austria; and Alois Lange and Felix Offner of Medical Hospital Feldkirch, Austria.

About Mayo Clinic Cancer Center

As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 507-538-7623.

###

About Mayo Clinic

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit MayoClinic.com or MayoClinic.org/news.

Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.

Source: http://www.mayoclinic.org/news2012-rst/7228.html?rss-feedid=1

brandon jennings the vow review luol deng culkin wooly mammoth no child left behind no child left behind

Planning to Leverage the Benefits Offered by Online Advertising ...

Online advertising is getting more popular. Businesses are increasingly using online advertising to gain potential customers. Though, there are various channels to promote a business, many business owners prefer online advertising as people today are turning to Internet to get information and purchase products and services.

Other reasons for them to choose online advertising are its cost effectiveness, measurability, local and global exposure and flexibility in targeting audience. Are you planning to leverage the benefits offered by online advertising? Here are some basics for you.

Get the basic knowledge
Having a website is not enough in today?s competitive online space. You need to smartly use various advertising methods like pop-up ads, video ads, display ads, text ads, pay-per-click (PPC) ads, Search Engine Optimization (SEO), social media, e-mail advertising, etc. to make your online advertising effective. For this, you need to have basic knowledge of them. You need to know what they are, how they work, how much you need to spend on each method, how effective they are, how to use them ? one at a time or all at a time, etc.

Be clear about the purpose of your online advertising
The main objective of online advertising is to promote your business to gain more traffic to your website. While promoting your business online, you need to be very clear on the purpose of the advertising ? brand awareness, publicity, target potential audiences and rank in search engines, etc.

Define the size of advertising budget
As discussed earlier, online advertising offers various advertising options, choose the one that suits your budget. Before you invest money into online advertising, figure out exactly how much money you need to spend and further how it will help you in generating leads and sales for your business.

PPC is generally a costly option but it will give immediate results as your website will be displayed on first page of search engines for your keywords. SEO is less expensive, but gives results in the long run. Take professional advice on which form of advertising best suits your business and allocate the budget.

Approach a reliable service provider
Promoting your business online on your own is bit risky as you are not aware of the marketing strategies that will help your business gain popularity. Therefore, it is advisable to approach a reliable service provider, who will effectively help you in promoting your business. While choosing a service provider, research thoroughly on the Internet and pick the one who is in the industry for quite some time serving clients.

You need to track the performance of the ad campaign and measure the results continuously. This way, you will have a clear picture whether your campaign is going on the right track or not. However, if you take help of professional service provider, he will track the performance for you and send details regularly.

Marvist offers small business Internet marketing services across the U.S.A. Marvist specializes in professional SEO services, local search optimization and PPC Management. Since establishment in 2005, Marvist has earned the goodwill of clients by its uncompromising commitment to its values while delivering expert services.

Source: http://articlelib.org/planning-to-leverage-the-benefits-offered-by-online-advertising-know-the-basics/

Microsoft Surface Candy Crowley binders of women Alexis Wright presidential debates seahawks Felix Baumgartner

Gene therapy reported to cure leukemia in young girl

On December 9, University of Philadelphia cancer researchers announced that they had cured leukemia in a young girl near death from leukemia. They reprogrammed seven-year-old Emily Whitehead?s own immune cells to attack an aggressive form of childhood leukemia, acute lymphoblastic leukemia (ALL). ALL is the most common childhood leukemia, and also the most common childhood cancer.

Pediatric oncologist Stephan A. Grupp, M.D., Ph.D., of The Children?s Hospital of Philadelphia, and colleagues from the University of Pennsylvania presented updated results of the clinical trial involving these engineered cells at the American Society of Hematology (ASH) annual meeting on December 9 in Atlanta, Georgia. The researchers noted that their innovative experimental therapy resulted in a complete response when Emily relapsed after conventional treatment. The innovative experimental therapy used bioengineered T cells, custom-designed to multiply rapidly in the patient, and then destroy leukemia cells. After the treatment, Emily?s doctors found that she had no evidence of cancer.

Dr. Grupp?s research builds on his ongoing collaboration with Penn scientists who originally developed the modified T cells as a treatment for B-cell leukemias. In August 2011, the Penn team reported on early results of a trial using this cell therapy in adult chronic lymphocytic leukemia (CLL) patients in August of 2011. Carl H. June, MD, of the Perelman School of Medicine at the University of Pennsylvania, leads this research group, which along with Dr. Grupp?s work, is presenting new data at the ASH meeting showing that nine of 12 patients with advanced leukemias in the clinical trial, including two children who responded to treatment with CTL019 cells.

Emily is among the nine patients who responded to the therapy.is the 7-year-old with acute lymphoblastic leukemia (ALL). Dr. Grupp and his colleagues adapted the CLL treatment to combat ALL. Currently, oncologists (cancer specialists) can cure approximately 85% of ALL cases, the remaining 15% of such cases stubbornly resist treatment. The investigators note that the CTL019 therapy, formerly called CART19, represents a new approach in cancer treatment. T cells are the mainstay of the immune system; they recognize and attack invading disease cells. However, cancer cells can evade detection by T cells. Chimeric antigen receptor T cells (CAR T cells) are engineered to specifically target B cells, which become cancerous in certain leukemias, such as ALL and CLL, as well as types of lymphoma, another cancer of the immune cells.

CD19 is a protein found only on the surface of B cells. By creating an antibody that recognizes CD19, and physically connecting that antibody to T cells, the researchers have created a guided missile that locks in on and kills B cells, thereby attacking B-cell leukemia. In using the CTL019 treatment in his pediatric patient, Dr. Grupp found that the very activity that destroyed leukemia cells also stimulated a highly activated immune response called a cytokine release syndrome. The child became very ill and had to be admitted to the intensive care unit.

Grupp and his team decided to counteract these toxic side effects with the use of two immunomodulating drugs that reduced the overactive immune response and rapidly relieved the child?s treatment-related symptoms. These results were effective enough that this approach is now being successfully incorporated into CTL019 treatments for adults as well. The immunomodulating drugs did not interfere with the CTL019 therapy?s anti-leukemia benefits, which have persisted six months after the infusion of cell therapy. This persistence is essential, because the engineered T cells remain in the patient?s body to protect against a recurrence of the cancer. Dr. Grupp explained, ?These engineered T cells have proven to be active in B cell leukemia in adults. We are excited to see that the CTL019 approach may be effective in untreatable cases of pediatric ALL as well. Our hope is that these results will lead to widely available treatments for high-risk B cell leukemia and lymphoma, and perhaps other cancers in the future.?

?This type of pioneering research addresses the importance of timing when considering experimental therapies for relapsed patients,? added Susan R. Rheingold, MD, one of the investigators in the Children?s Hospital program for children with relapsed leukemia. Sheadded, ?To ensure newly relapsed patients with refractory leukemia meet criteria for options like CTL019, we must begin exploring these innovative approaches earlier than ever before. Having the conversation with families earlier provides them more treatment options to offer the best possible outcome.?

Reference: University of Pennsylvania

Source: http://www.emaxhealth.com/11306/gene-therapy-reported-cure-leukemia-young-girl

dan savage new world trade center kellen moore ryan braun bryce harper may day

Youtube app updated with new 10-inch tablet layout

There's an update to the Youtube app waiting for you in the Google Play store, and if you're using a 10-inch tablet (like the Nexus 10), you're in for a treat. The update adds a new layout for large screen devices that brings a great two-pane experience to everyone's favorite video service.

The update uses the concept of Android fragments, where both can act independently yet have influence over each other. The smaller fragment on the left allows for things like app navigation and selection, and your content appears to the right. It's a great way to build apps for large screen devices, and allows one app to have the best UI and layout for any size screen.

Hit the link above for the update, or just check your Google Play notifications.

Via: @WinDroidGuy

Source: http://feedproxy.google.com/~r/androidcentral/~3/PAFz3aCusg4/story01.htm

new smyrna beach st. joseph puerto rico primary manning peyton florida state meghan mccain

Telecommunications - Mexico - S&P affirms Axtel's CCC+ ratings with negative outlook

By Business News Americas staff reporters

Ratings agency Standard & Poor's (S&P) affirmed its CCC+ ratings of Mexican telco Axtel's long-term corporate credit and senior unsecured notes, and s...

...

This news article is one of hundreds published daily by Business News Americas about the commodities, markets, movements, companies, projects, economics and politics integral to the development of Latin America. Including news and insight from South America, Central America and the Caribbean, BNamericas includes telecommunications insight and forecasts for business opportunities in Mexico. The business development service focuses on major projects, active companies, such as Standard & Poor's International LLC and Tel?fonos de M?xico, S.A.B. de C.V.; and business and sales contacts, providing networking opportunities with leading executives throughout Latin America.

Source: http://member.bnamericas.com/news/telecommunications/s-p-affirms-axtels-ccc_-ratings-with-negative-outlook

cooking a turkey toysrus nfl standings how to carve a turkey ipad 2 Belk Macys Thanksgiving Day Parade 2012

The Stoner Channel: Top Flight Parkour, 2-Pac at the HoB, and Video Games at the End Times

More »

Source: http://feeds.gawker.com/~r/gizmodo/full/~3/K4gSFzyAqjY/

tampa bay buccaneers birdman whip it gabby giffords gabby giffords geithner gabrielle giffords

Butch jones, Saugatuck native, hired as Tennessee football coach

Tennessee selected Cincinnati's Butch?Jones as its fourth football coach in six seasons, ending a tumultuous couple of days for both parties.

The university has scheduled a news conference for 2:30 p.m. Friday to announce the hiring, which was first reported by VolQuest.com. Cincinnati already has announced Jones' resignation.

"I would like to thank Butch?Jones for his time at the University of Cincinnati," Bearcats' athletic director Whit Babcock said in a release. "With that said, we are excited about the future of this program and this job will be extremely attractive nationally. Our search will begin immediately."

The 44-year-old Jones has a 50-27 record in six seasons as a head coach. He went 27-13 in three seasons at Central Michigan and was 23-14 at Cincinnati the last three years. Jones now faces the task of rebuilding a former Southeastern Conference power that has posted three consecutive losing seasons.

Tennessee had been seeking a new coach since the Nov. 18 firing of Derek Dooley, who went 15-21 in his three-year tenure. The Volunteers contacted ESPN analyst and former Super Bowl-winning coach Jon Gruden, who indicated he wasn't interested. The Vols then pursued Charlie Strong, who said Thursday he had turned down their offer and would stay at Louisville.

On the same day Strong made his announcement, Jones was rejecting an offer to take over Colorado's program. Jones also had been linked to the Purdue coaching job before withdrawing his name from consideration.

Jones will become Tennessee's fourth coach in a six-season stretch, not including offensive coordinator Jim Chaney's stint as interim head coach in the 2012 season finale after Dooley's dismissal. Phillip Fulmer was fired in 2008 after posting a 152-52 record. Kiffin coached Tennessee in 2009 before leaving for Southern California. Dooley lasted three years.

After winning at least eight games for 16 consecutive seasons from 1989-2004 and posting double-digit wins in nine of those years, Tennessee hasn't earned more than seven victories in any of its last five seasons. The Vols went 5-7 this fall for their fifth losing season over the last eight years. This also marks the first time since 1909-11 that Tennessee has finished below .500 three years in a row.

Tennessee athletic director Dave Hart said at the start of the search that head coaching experience was "critically important" and that he wanted a coach who "knows the difficulty of climbing the ladder in the SEC." Jones lacks SEC experience, but he has a career winning percentage of .649. Jones' teams have earned at least a share of a conference title in four of his six seasons as a head coach.

After succeeding Notre Dame coach Brian Kelly at Central Michigan and Cincinnati, Jones maintained the momentum his predecessor had established at each school.

Central Michigan won two Mid-American Conference championships and posted a combined league record of 22-3 in Jones' three-year stint. Jones went 4-8 in his first year at Cincinnati, but the Bearcats are 19-6 since and have tied for first place in the Big East each of the last two seasons. Cincinnati's 2011 season included a 45-23 loss at Tennessee.

Jones signed a contract extension after the 2011 season that includes a $1.4 million buyout if he leaves before Jan. 1.

Jones' background as an assistant is entirely on offense, but one of his biggest challenges at Tennessee initially will be strengthening a defense that allowed the most points (35.7) and yards (471.4) per game of any SEC team this season. The Vols hadn't allowed that high a scoring average since 1893, when they gave up 42.7 points per game while playing a six-game schedule. They hadn't yielded that many yards per game since at least 1950, the earliest year Tennessee's sports information department has that statistic on file.

The makeup of Jones' first offense at Tennessee also remains uncertain, at least for now.

Starting quarterback Tyler Bray and star wide receivers Cordarrelle Patterson and Justin Hunter all are projected as first- or second-round draft picks if they choose to turn pro rather than returning to school for their senior seasons. Bray threw for 3,612 yards and 34 touchdowns this year to rank second on Tennessee's single-season list in both categories, behind Peyton Manning's 3,819 yards and 36 touchdown passes in 1997. Hunter caught 73 passes for 1,083 yards and nine touchdowns. Patterson gained a school-record 1,858 all-purpose yards.

Junior offensive tackle Ja'Wuan James also has been mentioned as a possible draft candidate.

Source: http://www.hollandsentinel.com/sports/x1233656079/Butch-jones-Saugatuck-native-hired-as-Tennessee-football-coach

affordable care act the line us soccer bobby brown arrested the happening black panthers mauritania